TIRZ-GLP2 30mg

$175.00

Tirzepatide-GLP2 a dual action peptide GIP and GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, administered via weekly subcutaneous injections.

Key Components and Benefits:

  • Substantial Weight Loss: Losing 15–22% of their body weight, with some losing over 20%

  • Significant HbA1c Reduction: It effectively lowers blood sugar in Type 2 diabetics

  • Appetite Suppression & Reduced Cravings: The dual action, specifically acting on the GIP receptor, reduces appetite and calorie intake more effectively.

  • Reduced Visceral Fat: It specifically targets deep belly fat, lowering metabolic risk.

  • Cardiovascular and Metabolic Health Improvements: It can improve blood pressure and lipid profiles, reducing cardiovascular risk.

  • Slows Gastric Emptying: Promotes a feeling of fullness for a longer duration after eating.

Tirzepatide-GLP2 a dual action peptide GIP and GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, administered via weekly subcutaneous injections.

Key Components and Benefits:

  • Substantial Weight Loss: Losing 15–22% of their body weight, with some losing over 20%

  • Significant HbA1c Reduction: It effectively lowers blood sugar in Type 2 diabetics

  • Appetite Suppression & Reduced Cravings: The dual action, specifically acting on the GIP receptor, reduces appetite and calorie intake more effectively.

  • Reduced Visceral Fat: It specifically targets deep belly fat, lowering metabolic risk.

  • Cardiovascular and Metabolic Health Improvements: It can improve blood pressure and lipid profiles, reducing cardiovascular risk.

  • Slows Gastric Emptying: Promotes a feeling of fullness for a longer duration after eating.